3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
12
Observational
2
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
1388
Neoplasms
1167
Colorectal Neoplasms
626
Lung Neoplasms
562
Prostatic Neoplasms
538
Carcinoma, Non-Small-Cell Lung
444
Carcinoma, Hepatocellular
296
Stomach Neoplasms
272
Pancreatic Neoplasms
270
Colonic Neoplasms
264
Ovarian Neoplasms
231
Head and Neck Neoplasms
228
Rectal Neoplasms
221
Melanoma
216
Multiple Myeloma
204
Uterine Cervical Neoplasms
198
Lymphoma
195
Leukemia
193
Precursor Cell Lymphoblastic Leukemia-Lymphoma
191
Neoplasm Metastasis
178
Carcinoma, Renal Cell
177
Brain Neoplasms
174
Esophageal Neoplasms
173
Leukemia, Myeloid, Acute
158
Urinary Bladder Neoplasms
138
Recurrence
123
Polycystic Ovary Syndrome
122
Liver Neoplasms
119
Hematologic Neoplasms
117
Endometrial Neoplasms
107
Interventions
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Observational
×
Anal Canal Carcinoma
×
Clear all
NCT04626466
2024-01-11
MIFADORESOL
Institut de cancérologie Strasbourg Europe
Completed
100 enrolled
NCT03465501
2018-03-14
BOOST-CA
Institut Paoli-Calmettes
Completed
89 enrolled